Epigenomic Blood-Based Early Detection of Pancreatic Cancer Employing Cell-Free DNA

Early detection of pancreatic cancer (PaC) can drastically improve survival rates. Approximately 25% of subjects with PaC have type 2 diabetes diagnosed within 3 years prior to the PaC diagnosis, suggesting that subjects with type 2 diabetes are at high risk of occult PaC. We have developed an early...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical gastroenterology and hepatology 2023-07, Vol.21 (7), p.1802-1809.e6
Hauptverfasser:	Haan, David, Bergamaschi, Anna, Friedl, Verena, Guler, Gulfem D., Ning, Yuhong, Reggiardo, Roman, Kesling, Michael, Collins, Micah, Gibb, Bill, Hazen, Kyle, Bates, Steve, Antoine, Michael, Fraire, Carolina, Lopez, Vanessa, Malta, Roger, Nabiyouni, Maryam, Nguyen, Albert, Phillips, Tierney, Riviere, Michael, Leighton, Anna, Ellison, Christopher, McCarthy, Erin, Scott, Aaron, Gigliotti, Lauren, Nilson, Eric, Sheard, Judith, Peters, Melissa, Bethel, Kelly, Chowdhury, Shimul, Volkmuth, Wayne, Levy, Samuel
Format:	Artikel
Sprache:	eng
Schlagworte:	Early Cancer Detection Epigenomic Profiling Liquid Biopsy Machine Learning New-Onset Diabetes Pancreatic Cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!